Jarrod Longcor

CIK: 0001545565

Transaction Breakdown

Open Market Buys (P)3 (60.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CLRB

Cellectar Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

CLRB
Cellectar Biosciences, Inc.
Jul 7, 2026
Award(A)
Stock option (right to buy)
Direct
118K shares-
CLRB
Cellectar Biosciences, Inc.
May 7, 2026
Purchase(P)
Direct
8.7K shares at avg. $2.88$25K
CLRB
Cellectar Biosciences, Inc.
Jul 2, 2025
Purchase(P)
Direct
10K shares at avg. $4.99$50K
CLRB
Cellectar Biosciences, Inc.
Feb 14, 2025
Award(A)
Stock option (right to buy)
Direct
500K shares-
CLRB
Cellectar Biosciences, Inc.
Jan 10, 2025
Purchase(P)
Direct
30K shares at avg. $0.28$8K

		Type	Shares	Price		Ownership
Jul 7, 2026	CLRB Cellectar Biosciences, Inc.	Award(A) Stock option (right to buy)	118,000	-	-	Direct
May 7, 2026	CLRB Cellectar Biosciences, Inc.	Purchase(P)	8,680	$2.88	$24,998	Direct
Jul 2, 2025	CLRB Cellectar Biosciences, Inc.	Purchase(P)	10,000	$4.99	$49,900	Direct
Feb 14, 2025	CLRB Cellectar Biosciences, Inc.	Award(A) Stock option (right to buy)	500,000	-	-	Direct
Jan 10, 2025	CLRB Cellectar Biosciences, Inc.	Purchase(P)	30,000	$0.28	$8,400	Direct

1-5 of 5 transactions

About Longcor Jarrod

Longcor Jarrod (SEC CIK 0001545565) files insider reports with the SEC as Chief Operating Officer of Cellectar Biosciences, Inc. (CLRB).

Signal8 holds 5 ownership filings by Longcor Jarrod, all Form 4s, filed between Feb 18, 2025 and Jul 8, 2026. Those filings report 5 transactions, from Jan 10, 2025 to Jul 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Longcor Jarrod's filings is in FLORHAM PARK, NJ.

Recent filings by Longcor Jarrod

Jul 7, 2026: Grant or award of CLRB derivative securities (Form 4, code A).
May 7, 2026: Open-market purchase of CLRB shares (Form 4, code P).
Jul 2, 2025: Open-market purchase of CLRB shares (Form 4, code P).
Feb 14, 2025: Grant or award of CLRB derivative securities (Form 4, code A).
Jan 10, 2025: Open-market purchase of CLRB shares (Form 4, code P).

Other insiders filing for Cellectar Biosciences, Inc. (CLRB)

Loren Stefan, Officer
Kolean Chad J, CFO
DRISCOLL FREDERICK W, Director
Chanan-Khan Asher, Director
CARUSO JAMES V, President & CEO
Gu Andrew, Director

How to read Form 4 transaction codes